Clinical Research Practice DataLink

Organisation as named by public health-data sources.

Records naming this organisation

• This study is to test whether a machine learning approach developed in Israel can be used to accurately identify people who will be at risk of bowel cancer based on their GP record. (Registered study, PHE data release register (2017 to 2020) and UKHSA approvals register (2022 to 2024), 2017-04-21)
• PHE data release ODR1718_011 to Clinical Research Practice DataLink (Registered study, PHE data release register (2017 to 2020) and UKHSA approvals register (2022 to 2024), 2017-04-24)
• Lay summary published by CPRD: https://www.cprd.com/protocol/post-authorization-safety-study-evaluation-neoplasm-events-users-mirabegron-and-other (Registered study, PHE data release register (2017 to 2020) and UKHSA approvals register (2022 to 2024), 2017-05-31)
• This project will explore whether weight loss can be used to predict cancer or any other serious disease, within 24 months of a patient reporting weight loss to their General Practitioner (GP). (Registered study, PHE data release register (2017 to 2020) and UKHSA approvals register (2022 to 2024), 2017-08-17)
• Lay summary published by CPRD at: https://www.cprd.com/protocol/hormone-therapy-relation-risks-second-cancers-and-mortality-among-women-and-men (Registered study, PHE data release register (2017 to 2020) and UKHSA approvals register (2022 to 2024), 2017-08-31)
• Lay summary published by CPRD at: https://www.cprd.com/protocol/understanding-diagnostic-pathway-brain-tumours-adults-and-its-potential-impact-clinical (Registered study, PHE data release register (2017 to 2020) and UKHSA approvals register (2022 to 2024), 2017-09-01)
• Lay summary published by CPRD at: https://www.cprd.com/protocol/diagnostic-utility-inflammatory-markers-primary-care-prospective-cohort-study (Registered study, PHE data release register (2017 to 2020) and UKHSA approvals register (2022 to 2024), 2017-09-28)
• Lay summary published by CPRD at: https://www.cprd.com/protocol/predicting-prostate-cancer-progression-associations-between-routine-primary-care-data-and (Registered study, PHE data release register (2017 to 2020) and UKHSA approvals register (2022 to 2024), 2017-10-30)
• This study aims to find out how being diagnosed with cancer affects an individual’s lifetime risk of developing different cardiovascular diseases (diseases that affect the heart and blood vessels). (Registered study, PHE data release register (2017 to 2020) and UKHSA approvals register (2022 to 2024), 2017-12-14)
• Lay summary published by CPRD at https://www.cprd.com/protocol/understanding-clinical-and-healthcare-predictors-diagnostic-timeliness-patients-suspected (Registered study, PHE data release register (2017 to 2020) and UKHSA approvals register (2022 to 2024), 2018-01-09)
• PHE data release ODR1718_347 to Clinical Research Practice DataLink (Registered study, PHE data release register (2017 to 2020) and UKHSA approvals register (2022 to 2024), 2018-01-16)
• Lay summary published by CPRD at https://www.cprd.com/protocol/weight-loss-predictor-cancer-and-serious-disease-primary-care (Registered study, PHE data release register (2017 to 2020) and UKHSA approvals register (2022 to 2024), 2018-02-13)
• Lay summary published by CPRD at https://www.cprd.com/protocol/evaluating-impact-nice-guidelines-suspected-cancers-respect-diagnostic-interval-and-other (Registered study, PHE data release register (2017 to 2020) and UKHSA approvals register (2022 to 2024), 2018-06-06)
• Lay summary published by CPRD at https://www.cprd.com/protocol/post-authorization-safety-study-evaluation-neoplasm-events-users-mirabegron-and-other (Registered study, PHE data release register (2017 to 2020) and UKHSA approvals register (2022 to 2024), 2018-06-20)
• Lay summary published by CPRD at https://www.cprd.com/protocol/natural-history-atrial-fibrillation-united-kingdom (Registered study, PHE data release register (2017 to 2020) and UKHSA approvals register (2022 to 2024), 2018-06-26)
• Lay summary published by CPRD at https://www.cprd.com/bibliography/cohort-study-risk-lymphoma-and-skin-cancer-users-topical-tacrolimus-pimecrolimus-and-0 (Registered study, PHE data release register (2017 to 2020) and UKHSA approvals register (2022 to 2024), 2018-07-17)
• Lay summary published by CPRD at https://www.cprd.com/protocol/abdominal-pain-primary-care-establishing-clinical-profile-and-diagnostic-pathway (Registered study, PHE data release register (2017 to 2020) and UKHSA approvals register (2022 to 2024), 2018-07-18)
• Lay summary published by CPRD at https://www.cprd.com/protocol/impact-type-2-diabetes-survival-patients-cancer-independent-its-effect-survival-individuals (Registered study, PHE data release register (2017 to 2020) and UKHSA approvals register (2022 to 2024), 2018-07-20)
• Lay summary published by CPRD athttps://www.cprd.com/protocol/down-syndrome-co-morbidities-life-expectancy-and-causes-mortality (Registered study, PHE data release register (2017 to 2020) and UKHSA approvals register (2022 to 2024), 2018-08-10)
• Lay summary published by CPRD at https://www.cprd.com/protocol/associations-between-inflammatory-and-non-inflammatory-oral-mucosal-diseases-and-head-and (Registered study, PHE data release register (2017 to 2020) and UKHSA approvals register (2022 to 2024), 2018-08-10)
• Lay summary published by CPRD at https://www.cprd.com/protocol/5-alpha-reductase-inhibitors-benign-prostate-hyperplasia-and-risk-urological-cancers-and (Registered study, PHE data release register (2017 to 2020) and UKHSA approvals register (2022 to 2024), 2018-08-13)
• Lay summary published by CPRD at https://www.cprd.com/protocol/real-world-evidence-oncology-england-epidemiology-patient-characteristics-and-survival (Registered study, PHE data release register (2017 to 2020) and UKHSA approvals register (2022 to 2024), 2018-09-07)
• Lay summary published by CPRD at https://www.cprd.com/protocol/real-world-evidence-oncology-england-treatment-patterns-and-healthcare-resource-utilization (Registered study, PHE data release register (2017 to 2020) and UKHSA approvals register (2022 to 2024), 2018-09-10)
• lay summary published by CPRD at: https://www.cprd.com/protocol/risk-factors-venous-thromboembolism-and-serious-bleeding-events-patients-active-breast (Registered study, PHE data release register (2017 to 2020) and UKHSA approvals register (2022 to 2024), 2018-09-25)
• Lay summary published by CPRD at https://www.cprd.com/protocol/are-patients-high-normal-platelet-counts-increased-risk-cancer-norma-study (Registered study, PHE data release register (2017 to 2020) and UKHSA approvals register (2022 to 2024), 2018-10-02)
• Lay summary published by CPRD at https://www.cprd.com/protocol/hormone-therapy-relation-risks-second-cancers-and-mortality-among-women-and-men (Registered study, PHE data release register (2017 to 2020) and UKHSA approvals register (2022 to 2024), 2018-10-03)
• Lay summary published by CPRD at https://www.cprd.com/protocol/hormone-therapy-relation-risks-second-cancers-and-mortality-among-women-and-men (Registered study, PHE data release register (2017 to 2020) and UKHSA approvals register (2022 to 2024), 2018-10-03)
• Lay summary published by CPRD at https://www.cprd.com/protocol/healthcare-resource-utilisation-associated-hepatocellular-carcinoma-uk (Registered study, PHE data release register (2017 to 2020) and UKHSA approvals register (2022 to 2024), 2018-10-03)
• PHE data release ODR1819_207 to Clinical Research Practice DataLink (Registered study, PHE data release register (2017 to 2020) and UKHSA approvals register (2022 to 2024), 2018-10-29)
• https://www.cprd.com/protocol/using-predictive-analytics-improve-patient-outcomes-neuroendocrine-tumours (Registered study, PHE data release register (2017 to 2020) and UKHSA approvals register (2022 to 2024), 2018-11-15)
• PHE data release ODR1819_109 to Clinical Research Practice DataLink (Registered study, PHE data release register (2017 to 2020) and UKHSA approvals register (2022 to 2024), 2018-12-06)
• PHE data release ODR1819_220 to Clinical Research Practice DataLink (Registered study, PHE data release register (2017 to 2020) and UKHSA approvals register (2022 to 2024), 2018-12-06)
• PHE data release ODR1819_235 to Clinical Research Practice DataLink (Registered study, PHE data release register (2017 to 2020) and UKHSA approvals register (2022 to 2024), 2018-12-06)
• An ongoing partnership between Public Health England and the Clinical Practice Research Datalink (CPRD) to extend the uses and richness of primary care de-personalised data collected by the Clinical… (Registered study, PHE data release register (2017 to 2020) and UKHSA approvals register (2022 to 2024), 2018-12-12)
• PHE data release ODR1819_279 to Clinical Research Practice DataLink (Registered study, PHE data release register (2017 to 2020) and UKHSA approvals register (2022 to 2024), 2019-02-01)
• Lay summary published by CPRD: https://www.cprd.com/protocol/do-systemic-antibiotics-affect-effectiveness-chemotherapy-malignant-cancers-cohort-study (Registered study, PHE data release register (2017 to 2020) and UKHSA approvals register (2022 to 2024), 2019-02-11)
• Lay summary published by CPRD: https://www.cprd.com/protocol/natural-history-and-heterogeneity-progression-dementia-united-kingdom (Registered study, PHE data release register (2017 to 2020) and UKHSA approvals register (2022 to 2024), 2019-04-11)
• PHE data release ODR1920_013 to Clinical Research Practice DataLink (Registered study, PHE data release register (2017 to 2020) and UKHSA approvals register (2022 to 2024), 2019-04-30)
• PHE data release ODR1920_058 to Clinical Research Practice DataLink (Registered study, PHE data release register (2017 to 2020) and UKHSA approvals register (2022 to 2024), 2019-05-31)
• Lay summary published by CPRD at https://www.cprd.com/protocol/guideline-discordant-diagnostic-care-when-do-primary-care-referrals-not-reflect-guidelines (Registered study, PHE data release register (2017 to 2020) and UKHSA approvals register (2022 to 2024), 2019-07-08)
• Lay summary published by CPRD: https://www.cprd.com/protocol/association-cancer-and-autism-spectrum-condition-uk-population (Registered study, PHE data release register (2017 to 2020) and UKHSA approvals register (2022 to 2024), 2019-07-22)
• An ongoing partnership between Public Health England and the Clinical Practice Research Datalink (CPRD) to extend the uses and richness of primary care de-personalised data collected by the Clinical… (Registered study, PHE data release register (2017 to 2020) and UKHSA approvals register (2022 to 2024), 2019-09-12)
• Lay summary published by CPRD: https://www.cprd.com/protocol/ageing-inequalities-cohort-study-investigate-delay-diagnosis-and-inequalities-treatment (Registered study, PHE data release register (2017 to 2020) and UKHSA approvals register (2022 to 2024), 2020-01-31)
• Lay summary published by CPRD: https://www.cprd.com/protocol/weight-change-following-type-2-diabetes-diagnosis-and-incidence-cardiovascular-events-and (Registered study, PHE data release register (2017 to 2020) and UKHSA approvals register (2022 to 2024), 2020-03-19)
• PHE data release ODR1920_317 to Clinical Research Practice DataLink (Registered study, PHE data release register (2017 to 2020) and UKHSA approvals register (2022 to 2024), 2020-04-22)
• PHE data release ODR1920_260 to Clinical Research Practice DataLink (Registered study, PHE data release register (2017 to 2020) and UKHSA approvals register (2022 to 2024), 2020-05-07)
• An ongoing partnership between Public Health England and the Clinical Practice Research Datalink (CPRD) to extend the uses and richness of primary care de-personalised data collected by the Clinical… (Registered study, PHE data release register (2017 to 2020) and UKHSA approvals register (2022 to 2024), 2020-05-24)
• PHE data release ODR2021_080 to Clinical Research Practice DataLink (Registered study, PHE data release register (2017 to 2020) and UKHSA approvals register (2022 to 2024), 2020-10-01)
• PHE data release ODR2021_108 to Clinical Research Practice DataLink (Registered study, PHE data release register (2017 to 2020) and UKHSA approvals register (2022 to 2024), 2020-10-01)

Organisation name as the register gives it. Not matched to a company or institutional identifier here; the same organisation may appear under other spellings.